Credit Agricole’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Credit Agricole’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$330K	Sell	2,085 -13,771	-87%	-$1.86M	﹤0.01%	1262
2026 Q1	$2.03M	Sell	15,856 -15,582	-50%	-$1.95M	0.01%	884
2025 Q4	$3.83M	Buy	31,438 +30,240	+2,524%	+$3.47M	0.01%	676
2025 Q3	$120K	Buy	+1,198	New	+$108K	﹤0.01%	1092
2025 Q1	$331K	Buy	4,084 +3,022	+285%	+$270K	﹤0.01%	1069
2024 Q4	$95.6K	Buy	1,062 +538	+103%	+$52.1K	﹤0.01%	1158
2024 Q3	$51.8K	Buy	+524	New	+$51.5K	﹤0.01%	1147
2024 Q2	–	Sell	-857	Closed	-$71.5K	–	1152
2024 Q1	$71.5K	Sell	857 -2,306	-73%	-$214K	﹤0.01%	776
2023 Q4	$282K	Sell	3,163 -3,718	-54%	-$276K	﹤0.01%	669
2023 Q3	$502K	Buy	6,881 +1,020	+17%	+$81.5K	0.01%	417
2023 Q2	$488K	Sell	5,861 -15,089	-72%	-$1.26M	0.01%	363
2023 Q1	$1.6M	Buy	20,950 +2,254	+12%	+$187K	0.03%	241
2022 Q4	$1.55M	Sell	18,696 -7,332	-28%	-$594K	0.03%	263
2022 Q3	$2.06M	Buy	26,028 +2,446	+10%	+$206K	0.04%	226
2022 Q2	$1.75M	Buy	23,582 +3,742	+19%	+$281K	0.04%	262
2022 Q1	$1.78M	Sell	19,840 -10,371	-34%	-$958K	0.03%	262
2021 Q4	$3.38M	Buy	+30,211	New	+$3.64M	0.05%	197
2014 Q2	–	Sell	-153	Closed	-$7K	–	1663
2014 Q1	$7K	Buy	+153	New	+$7.83K	﹤0.01%	1521

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Credit Agricole's XBI Position: Q2 2026 in Review

Credit Agricole reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 87% in Q2 2026, selling an estimated $1.86M and leaving 2,085 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

Credit Agricole first reported a position in XBI in Q1 2014 and has held it in 18 quarters since. The position peaked at $3.83M in Q4 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Credit Agricole held 2,085 shares of State Street SPDR S&P Biotech ETF worth $330K as of Q2 2026.
Credit Agricole sold 13,771 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.86M.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1262 holding.
Credit Agricole first reported a position in State Street SPDR S&P Biotech ETF in Q1 2014 and has held it in 18 quarters since.
Credit Agricole's State Street SPDR S&P Biotech ETF position peaked at $3.83M in Q4 2025.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.